Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|11|1275-1281

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.11, 2016-07, pp. : 1275-1281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological interventions for the correction of ion transport defect in cystic fibrosis

By Becq Frédéric   Mettey Yvette  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1465-1483

Informa Healthcare

Access to resources Recommend Favorite

Rescuing Mutant CFTR: A Multi-task Approach to a Better Outcome in Treating Cystic Fibrosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 19, 2013-06 ,pp. : 3497-3508

Bentham Science Publishers

Access to resources Recommend Favorite

Cystic fibrosis transmembrane regulator (CFTR) modulators

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 471-474

Informa Healthcare

Access to resources Recommend Favorite

Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies

By  

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 683-693

Bentham Science Publishers

Access to resources Recommend Favorite

Stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels by flavonoids

By Illek B.   Machen T.E.   Widdicombe J.   Fischer H.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite